| Common name | Taurine |
| Synonyms | 2-Aminoethanesulfonic acid; β-Aminoethanesulfonic acid |
| CAS number | 107-35-7 |
| Molecular formula | C₂H₇NO₃S |
| Molecular weight | 125.15 g/mol |
| Appearance | White crystalline powder, odourless, slightly acidic taste |
| Assay | ≥99.0% (HPLC or potentiometric titration, USP/BP) |
| Melting point | 305°C (decomposes) |
| Solubility in water | 10.5 g/100 mL at 20°C |
| pH (10% aqueous solution) | 4.1–5.6 |
| Specific rotation | Optically inactive (achiral molecule) |
| Loss on drying | NMT 0.5% |
| Residue on ignition | NMT 0.1% |
| Heavy metals (total) | NMT 10 ppm |
| Lead / Arsenic | NMT 0.5 ppm / NMT 0.5 ppm |
| Microbial limits | TPC NMT 10³ CFU/g; absence of Salmonella, E. coli |
| Production method | Chemical synthesis (aziridine + SO₂ + NaOH route) |
| Regulatory status | USP/BP monograph; GRAS USA; functional food Japan; EU food supplement |
| Infant formula compliance | Meets EU 2016/127 and FDA 21 CFR 107.100 taurine requirements |
| Shelf life | 24 months (<25°C, dry, sealed) |
Every batch HPLC-assayed for ≥99% purity, heavy metals, microbial limits, and residual solvents. Used in pharmaceutical cardiac formulations — GMP documentation to pharmaceutical standard.
Assay ≥99.0% by HPLC and potentiometric titration. Identity confirmed by IR spectroscopy. Melting point 305°C verified. Related amino acid impurities and sulfate content profiled per USP/BP.
Synthetic grade tested for residual solvents (ICH Q3C limits). Aziridine residuals below detection limit. Sulfur dioxide below ICH Class 3 limits. Full ICH residual solvent profile on request.
Lead NMT 0.5 ppm; Arsenic NMT 0.5 ppm; Mercury NMT 0.1 ppm. TPC NMT 10³ CFU/g; absence of Salmonella and E. coli. Tested per USP/EP methods on each batch.
Full COA, MSDS, Certificate of Origin. USP/BP analytical certificates. FSSAI compliance for food applications. Halal/Kosher on request. Suitable for infant formula applications with full documentation.
Taurine serves three distinct end markets with different dosing rationales: pharmaceutical cardiac formulations (1.5–3g/day), sports supplements (1–2g pre-exercise), and energy drinks (1g/250mL standard). All use the same ingredient — the application context and dose separate them.
Taurine is used in cardiac medicine in Japan in clinical and medical-nutrition formats. Inclusion levels are set by the finished-product formulator and by the claim position permitted in the destination market. The relevant supply characteristics are its high water solubility (10.5 g/100 mL at 20°C), the compendial ≥99.0% USP/BP specification and the 40–80 mesh particle size. Note that it is insoluble in alcohol, so aqueous or aqueous-alcohol systems are required. Ca²⁺ in cardiomyocytes, reduces oxidative stress in heart tissue. Specify pharmaceutical grade with USP/BP COA for this application.
1–2g taurine 60–90 minutes pre-exercise reduces exercise-induced oxidative damage, attenuates post-exercise muscle soreness (DOMS), and extends time-to-exhaustion in endurance events. Mechanism: osmotic regulation in muscle cells, calcium-mediated force production support. Food grade is appropriate; cost advantage over pharma grade at these high-volume sports doses.
The energy drink industry standard is 1g taurine per 250mL can (Red Bull, Monster, and most major brands). Taurine is beverage-optimised: highly soluble, thermally stable through pasteurisation and UHT, pH stable at acidic beverage pH (2.5–4.0), and flavour-neutral. Specify beverage-grade or food-grade. Taurine counterbalances caffeine's pro-arrhythmic effects and reduces jitteriness.
Taurine is conditionally essential for neonates (premature infants cannot synthesise sufficient amounts) and is mandated in EU/FDA infant formula regulations at 4–6mg/100kcal. For eye health: taurine deficiency causes irreversible photoreceptor degeneration — supplementation is used in retinal protective formulations. Pharmaceutical grade with infant formula documentation required for neonatal applications.
Supplied as a bulk ingredient for further manufacture. Buyers are responsible for compliance with the regulations of their destination market. This product is not intended to diagnose, treat, cure or prevent any disease.
We use cookies for analytics and to measure our advertising. Essential cookies are always on. Privacy policy